A phase I study of gemcitabine + dasatinib (gd) or gemcitabine + dasatinib + cetuximab (GDC) in refractory solid tumorsMettu, Niharika B.; Niedzwiecki, Donna; Rushing, Christel; Nixon, Andrew B.; Jia, Jingquan; Haley, Sherri; Honeycutt, Wanda; Hurwitz, Herbert; Bendell, Johanna C.; Uronis, Hope · Cancer Chemotherapy and Pharmacology · 2019

Dasatinib cessation after deep molecular response exceeding 2 years and natural killer cell transition during dasatinib consolidationKumagai, Takashi; Nakaseko, Chiaki; Nishiwaki, Kaichi; Yoshida, Chikashi; Ohashi, Kazuteru; Takezako, Naoki; Takano, Hina; Kouzai, Yasuji; Murase, Tadashi; Matsue, Kosei; Morita, Satoshi; Sakamoto, Junichi; Wakita, Hisashi; Sakamaki, Hisashi; Inokuchi, Koiti · Cancer Science · 2017

Design, Synthesis, and Evaluation of Dasatinib-Amino Acid and Dasatinib-Fatty Acid Conjugates as Protein Tyrosine Kinase InhibitorsTiwari, Rakesh K; Brown, Alex; Shirazi, Amir Nasrolahi; Bolton, Jared; Tse, Amanda; Verkhivker, Gennady; Parang, Keykavous; Sun, Gongqin · ChemMedChem · 2016

Efficacy of dasatinib in conjunction with α-interferon for the treatment of imatinib-resistant and dasatinib-resistant Ph+ acute lymphoblastic leukemiaVisani, G; Piccaluga, P; Malagola, M; Isidori, A · 2009

Long-term use of dasatinib in patients with metastatic castration-resistant prostate cancer after receiving the combination of dasatinib and docetaxelAraujo, John; Trudel, ; Paliwal, · Cancer Management and Research · 2013

Efficacy and Tolerability after Unusually Low Doses of Dasatinib in Chronic Myeloid Leukemia Patients Intolerant to Standard-Dose Dasatinib TherapySerpa, Mariana; Sanabani, Sabri S.; Bendit, Israel; Seguro, Fernanda; Xavier, Flávia; Barroso, Cláudia Bitti; Conchon, Monika; Dorlhiac-Llacer, Pedro Enrique · Clinical Medicine Insights: Oncology · 2010

Simultaneous Determination of Methotrexate, Dasatinib and its Active Metabolite N- Deshydroxyethyl Dasatinib in Rat Plasma by LC-MS/MS: Method Validation and Application to Pharmacokinetic StudyS. Thappali; K. Varanasi; S. Veeraraghavan; S. Vakkalanka; M. Khagga · 2012

Once-daily Dasatinib: Expansion of Phase II Study Evaluating Safety and Efficacy of Dasatinib in Patients With Metastatic Castration-resistant Prostate CancerEvan Y. Yu; Christophe Massard; Mitchell E. Gross; Michael A. Carducci; Stephane Culine; Gary Hudes; Edwin M. Posadas; Cora N. Sternberg; George Wilding; Géralyn C. Trudel; Prashni Paliwal; Karim Fizazi · 2011

Biperiden/trihexyphenidylReactions Weekly · 1995

NitrendipineReactions Weekly · 2003

ScopolamineReactions Weekly · 2007

ScopolamineReactions Weekly · 2012

ScopolamineReactions Weekly · 2009

Centella asiaticaReactions Weekly · 2011

Daunorubicin/mitoxantroneReactions Weekly · 2007

AnthracyclinesReactions Weekly · 1991